Adicet Bio Inc (ACET)

While targeting the therapeutic side of the healthcare sector can be quite lucrative, nothing matches the excitement of biotech penny stocks. Of course, the excitement…

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Jun 27, 2023

It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on Tuesday morning!

7 Biotech Stocks With Huge Return Potential for Long-Term Investors

By Josh Enomoto, InvestorPlace Contributor Apr 26, 2023

Although a wildly speculative sector, the low-cost, high-potential biotech stocks to buy and hold may deliver the goods for gamblers.

7 Biotech Stocks That Could Be the Next Big Thing

By Josh Enomoto, InvestorPlace Contributor Mar 15, 2023

Although speculation might be a tough call at this juncture, these biotech stocks and their underlying science might be compelling enough.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Dec 12, 2022

We're starting off the week with a look at the biggest pre-market stock movers traders need to know about for Monday morning!

7 Cheap Biotech Stocks to Buy Now

By Shanthi Rexaline Aug 3, 2022

These cheap biotech stocks to buy offer investors a way to get ready for the inevitable comeback in the biopharmaceutical sector.

Jones upgrades Adicet to buy, cites upcoming catalysts (NASDAQ:ACET)

From Seeking Alpha Feb 13, 2024

Jones Trading has upgraded its rating of Adicet Bio (ACET) to buy, citing “robust” interest in the cell therapy space. Jones said it sees approximately ten upco

Adicet Bio announces pricing of public offering (NASDAQ:ACET)

From Seeking Alpha Jan 23, 2024

Adicet Bio announces the pricing of its public offering, with expected gross proceeds of $85.2M, to close on January 25, 2024.

Adicet Bio stock sinks on proposed public offering (NASDAQ:ACET)

From Seeking Alpha Jan 22, 2024

Adicet Bio starts underwritten public offering, causing its stock to plummet by 15.3%.

Adicet Bio stock rallies 26% on pipeline, cash runway updates (NASDAQ:ACET)

From Seeking Alpha Jan 4, 2024

Adicet Bio (ACET) stock rallied 26% after it issued a pipeline update and said it had enough cash to fund operations into the second half of 2025. Read more here.

JMP downgrades Adicet to market perform, citing study delay (ACET)

From Seeking Alpha Jun 27, 2023

JMP Securities downgraded Adicet Bio (ACET) to market perform and removed its price target of $19, citing uncertainty about the start date for a pivotal study. Read more here.

Adicet Bio Stock Craters on Phase 1 Clinical Data

From TipRanks Dec 12, 2022

Midday trading for Adicet Bio on Monday (NASDAQ:ACET) turned sharply down. The company has lost over 36.7% so far in trading, and it all seems to be thanks to the

Adicet Bio Inc (ACET)

ACET Stock Earnings: Adicet Bio Beats EPS for Q1 2024

The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness

ACET Stock Earnings: Adicet Bio Meets EPS for Q4 2023

3 High-Risk Stocks That Could Pay Off in the Millions

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Adicet Bio Inc (ACET)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

ACET Stock Predictions, Articles, and Adicet Bio Inc News

Subscriber Sign in